Family Medicine: An Evidence-Based Approach to Patient Care (Nov 30 - Dec 03, 2020)

Family Medicine: An Evidence-Based Approach to Patient Care is organized by American Medical Seminars (AMS), Inc. and will be held from Nov 30 - Dec 03, 2020 at Lido Beach Resort, Sarasota, Florida, United States of America. This Course has been approved for a maximum of 20 AMA PRA Category 1 Credits™.

Description:
Day 1:
Irritable Bowel Syndrome:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Appraise possible etiologies for Irritable Bowel Syndrome.
• Select and utilize diagnostic criteria to identify IBS, based on the current medical evidence and expert recommendations.
• Use the current medical literature to assess and screen for other conditions that can present with similar IBS symptoms.
• Detect “red flag” signs and symptoms that should make one question the diagnosis of IBS.
• Formulate an EBM diagnostic evaluation for patients with signs and symptoms of IBS.
• Use the current medical literature to develop an EBM treatment plan for Irritable Bowel Syndrome.

Dyspepsia:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Appraise symptoms and common etiologies for dyspepsia.
• Use EBM to detect “alarm symptoms” that are suspicious for GI malignancy.
• Apply current medical evidence and expert guidelines to construct a diagnostic evaluation for Dyspepsia.
• Determine appropriate treatment for Dyspepsia based on current medical evidence and the likely etiology.

Evaluation and Treatment of Hypertensive Patients:
Upon completion of this session, using the most recent JNC Guidelines, the Cochrane Abstract Database and the evidence-based reports from Clinical Evidence, the participant should be able to: ^{EBM, GL, COMP}
• Employ the non-pharmacologic treatment options to manage hypertension.
• Specify the pharmacologic treatment options for patients with compelling indications based upon JNC Guidelines.
• Formulate the therapeutic goal for controlling blood pressure in different patient populations and the combination of medications that can achieve that goal.
• Distinguish the side effect risks for each class of antihypertensive medications. 

Treating Patients with Type 2 Diabetes Mellitus:
Upon completion of this session, using the American Diabetes Association, the European Association for the Study of Diabetes Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM, GL, COMP}
• Evaluate the therapeutic goals in treating type 2 diabetes and their impact on morbidity and mortality.
• Recommend the approach for choosing an oral hypoglycemic agent to treat type 2 diabetes.
• Specify the clinical situations that would require the use of insulin to treat type 2 diabetes and the probable dosage form and average amounts required for control of A1c.
• Develop the therapeutic options for preventing diabetic complications.

Hyperlipidemia and CV Disease Prevention - A Review of the Literature and Recent AHA Guidelines:
Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}
• Create a diagnostic and treatment plan for patients based on the current evidence and AHA Guidelines.
• Explain similarities and differences between the most recent and previous guidelines.
• Identify areas of strength and weakness in the recent AHA Guidelines.
• Utilize the most recent cholesterol guidelines at the point of care.

Day 2:
Carpal Tunnel Syndrome:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Apply an evidence-based approach to the identification of Carpal Tunnel Syndrome.
• Detect clues that can help identify likely etiologies for Carpal Tunnel Syndrome.
• Construct a differential diagnosis for Carpal Tunnel Syndrome.
• Determine which patients would benefit from nerve conduction studies.
• Discriminate the severity of Carpal Tunnel Syndrome.
• Use EBM to select an appropriate treatment plan for Carpal Tunnel Syndrome

Migraine Headaches - Update on Diagnosis and Treatment:
Upon completion of this session, using the International Headache Society and U.S. Headache Consortium Guidelines and the National Guideline • Clearinghouse and the evidence-based reports from Clinical Evidence, the participant should be able to: ^{EBM, GL, COMP}
• Construct the approach for evaluating a patient with possible migraine headaches.
• Assess the advantages of supportive therapy and lifestyle changes in treating migraine headaches compared to pharmacologic therapy.
• Appraise the pharmacologic options for treating the acute pain of a migraine headache.
• Recommend a prophylactic therapy regimen for patients with recurrent migraine headaches.

Chronic Obstructive Pulmonary Disease (COPD): Evaluation and Treatment:
Upon completion of this session, using the ACCP GOLD guidelines, the AACVPR practice guidelines and the evidence-based reports from • Clinical Evidence, the participant should be able to: ^{EBM, GL, COMP}
• Analyze the role of cigarette smoking in the etiology and natural history of COPD.
• Formulate a treatment plan for the stages of COPD.
• Recommend the follow-up required to assess the therapeutic efficacy of the treatment options.

Evaluation and Treatment of Respiratory Infections Commonly Seen in Primary Care:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Formulate appropriate evaluation strategies for patients who present with respiratory conditions.
• Identify history and exam findings that help differentiate common respiratory conditions.
• Determine situations when antibiotics are appropriate for the treatment sinus infections.
• Utilize severity index tools in the evaluation of pneumonia.
• Utilize EBM to determine appropriate treatment for common respiratory conditions.
• Discuss some of the controversies in the treatment of common respiratory infections seen in primary care. 

Dementia:
Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}
• Detect symptoms consistent with the diagnosis of dementia.
• Distinguish dementia from treatable conditions that have similar presentations.
• Construct a diagnostic plan utilizing EBM and Expert Guidelines.
• Differentiate the common Dementia syndromes and distinguish the characteristics between them.
• Use EBM to design a treatment plan for dementia.

Day 3:
Delirium in the Elderly - Current Concepts:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Specify diagnostic features and common causes of delirium in seniors.
• Distinguish the causes of persistent delirium.
• Use evidence based medicine to formulate treatment approaches to delirious seniors.
• Recognize treatment options for intermittent agitation using evidence based medicine.

Geriatric Depression: Advances in Diagnosis and Treatment:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Differentiate the variety of clinical presentations of depressive disorders in seniors.
• Appraise the utility of, and plan to use, the Geriatric Depression Scale.
• Apply an evidence based approach to antidepressant drug therapy in seniors.
• Apply the evidence based recommendations for use of non-drug antidepressant therapy.

Adult Health Screening and Immunizations - Evidence-Based Approach:
Upon completion of this session, using the USPSTF and Cochrane Abstract Database, the participant should be able to: ^{EBM, GL, COMP}
• Apply the evidence-based recommendations for preventive screening tests for adults.
• Determine the immunizations required for adults.
• Appraise the side effects of adult immunizations.
• Select the contraindications for each adult immunization and their alternative therapy.
• Plan when screening tests can be discontinued in adults.

Venous Thromboembolism (VTE): Diagnosis and Treatment:
Upon completion of this session, using the ACCP and ATS Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM, GL, COMP}
• Determine the diagnostic testing for evaluating a patient for possible VTE.
• Apply the algorithm for diagnosing a pulmonary embolism in multiple clinical settings.
• Differentiate the advantages and disadvantages of outpatient treatment compared to inpatient treatment for venous thromboembolism (VTE).
• Order the frequency of monitoring and the adjustments needed for warfarin therapy in the treatment of VTE.

A Practical Approach to Falls and Urinary Incontinence in the Elderly:
Upon completion of this session, the participant should be able to: ^{EBM, GL, COMP}
• Integrate the concept of multifactorial causes underlying falls and employ the American Geriatrics Society Guidelines for the Prevention of Falls and urinary incontinence in seniors.
• Develop a full assessment approach to evaluate different causes, using detailed physical examination and functional performance evaluations.
• Differentiate the effects of normal aging from pathologic processes and adverse drug effects as risk factors for falls and incontinence.
• Apply NIH guidelines to formulate a preventative and therapeutic plan of care.

Day 4:
Vitamin B-12 and Vitamin D in Seniors:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Integrate the normal physiology of Vitamins B-12 and D.
• Differentiate the pathologic syndromes associated with B-12 and D deficiency.
• Develop an evidence based evaluation of B-12 and D deficiency for seniors.
• Develop an evidence based approach to treatment options for B-12 and D in seniors.

Advanced Nutritional Assessment and Therapy:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Integrate readily available clinical data to make accurate nutritional assessments in seniors.
• Relate metabolic changes in aging to assess risk for malnutrition.
• Apply an evidence based approach to treatment of undernutrition in seniors.

Anemia - A Finding, Not Yet a Diagnosis:
Upon completion of this session, using the Cochrane Abstract Database and AAFP Guidelines, the participant should be able to: ^{GL, COMP}
• Distinguish the etiologies for the common anemias.
• Construct the diagnostic evaluation to determine the etiology of each anemia.
• Develop the therapeutic options for each identified anemia.
• Formulate the appropriate follow-up evaluations for assessing the treatment efficacy.

Osteoporosis: Treatment and Prevention:
Upon completion of this session, using the USPSTF, NOF Guidelines and the Cochrane Abstract Database, the participant should be able to: ^{EBM, GL, COMP}
• Debate the importance of the risk factors for an osteoporosis fracture.
• Employ the diagnostic testing for patients at risk with osteoporosis.
• Select the therapeutic medication to treat osteoporosis based upon the indications and side effects.
• Assess the therapeutic role of repeating the DXA scan in patients treated for osteoporosis.

Sensible Prescribing Practices for the Elderly:
Upon completion of this session, the participant should be able to: ^{EBM, COMP}
• Appraise and appreciate the limits of published trials studies on drug safety and efficacy for seniors.
• Assess the subtle but significant drug side effects in the elderly.
• Distinguish undesirable prescribing practices and employ better approaches based on current evidence-based referenced literature.